Human neonatal thymus-derived mesenchymal stromal cells: Characterization, differentiation, and immunomodulatory properties

Tissue Engineering - Part A

Volumn 15, Issue 7, 2009, Pages 1787-1796

  Siepe, Matthias ^a   Thomsen, Andreas R ^b   Duerkopp, Natalie ^b   Krause, Ulf ^c   Förster, Katharina ^a   Hezel, Philip ^a   Beyersdorf, Friedhelm ^a   Schlensak, Christian ^a   Südkamp, Norbert P ^a   Bosse, Roland ^b   Niemeyer, Philipp ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Cellgenix GmbH   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; CELL PROLIFERATION; FLOWCHARTING; TISSUE ENGINEERING;

5-AZACYTIDINE; ADIPOGENIC; BONE MARROW STROMAL CELLS; CARDIAC SURGERY; CARDIOMYOCYTES; CELL POPULATIONS; CELL TRANSPLANTATION; CHONDROGENIC; COCULTURE; IMMUNE RESPONSE; IN-VITRO; MESENCHYMAL STROMAL CELLS; MORPHOLOGICAL CHARACTERISTIC; OSTEOGENIC; PERIPHERAL BLOOD MONONUCLEAR CELLS; STROMAL CELLS; SURFACE ANTIGEN;

CELL CULTURE;

AZACITIDINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN TISSUE; IMMUNOMODULATION; INFANT; MESENCHYME CELL; NEWBORN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; STROMA CELL; THYMUS;

EID: 67650685821     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2008.0356     Document Type: Article

References (37)

1. Eysteinsdottir, J.H., Freysdottir, J., Haraldsson, A., Stefansdottir, J., Skaftadottir, I., Helgason, H., and Ogmundsdottir, H.M. The influence of partial or total thymectomy during open heart surgery in infants on the immune function later in life. Clin Exp Immunol 136, 349, 2004.
2. Torfadottir, H., Freysdottir, J., Skaftadottir, I., Haraldsson, A., Sigfusson, G., and Ogmundsdottir, H.M. Evidence for extrathymic T cell maturation after thymectomy in infancy. Clin Exp Immunol 145, 407, 2006.
3. Choi, K.S., Shin, J.S., Lee, J.J., Kim, Y.S., Kim, S.B., and Kim, C.W. In vitro trans-differentiation of rat mesenchymal cells into insulin-producing cells by rat pancreatic extract. Biochem Biophys Res Commun 330, 1299, 2005.
4. Houghton, J., Stoicov, C., Nomura, S., Rogers, A.B., Carlson, J., Li, H., Cai, X., Fox, J.G., Goldenring, J.R., and Wang, T.C. Gastric cancer originating from bone marrow-derived cells. Science 306, 1568, 2004.
5. Lange, C., Bassler, P., Lioznov, M.V., Bruns, H., Kluth, D., Zander, A.R., and Fiegel, H.C. Liver-specific gene expression in mesenchymal stem cells is induced by liver cells. World J Gastroenterol 11, 4497, 2005.
6. da Silva, M.L., Chagastelles, P.C., and Nardi, N.B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119 (Pt 11), 2204, 2006.
7. Bartholomew, A., Sturgeon, C., Siatskas, M., Ferrer, K., McIntosh, K., Patil, S., Hardy, W., Devine, S., Ucker, D., Deans, R., Moseley, A., and Hoffman, R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30, 42, 2002.
8. Reyes, M., Lund, T., Lenvik, T., Aguiar, D., Koodie, L., and Verfaillie, C.M. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98,2615, 2001.
9. Rothstein, D.M., and Sayegh, M.H. T-cell costimulatory pathways in allograft rejection and tolerance. Immunol Rev 196, 85, 2003.
10. Le Blanc, K., Tammik, L., Sundberg, B., Haynesworth, S.E., and Ringden, O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57, 11, 2003.
11. Rasmusson, I., Ringden, O., Sundberg, B., and Le Blanc, K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 76, 1208, 2003.
12. Hoogduijn, M.J., Crop, M.J., Peeters, A.M., Van Osch, G.J., Balk, A.H., Ijzermans, J.N., Weimar, W., and Baan, C.C. Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities. Stem Cells Dev 16, 597, 2007.
13. Le Blanc, K., Tammik, C., Rosendahl, K., Zetterberg, E., and Ringden, O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31, 890, 2003.
14. Niemeyer, P., Kornacker, M., Mehlhorn, A., Seckinger, A., Vohrer, J., Schmal, H., Kasten, P., Eckstein, V., Sudkamp, N.P., and Krause, U. Comparison of immunological properties of bone marrow stromal cells and adipose tissue-derived stem cells before and after osteogenic differentiation in vitro. Tissue Eng 13, 111, 2007.
15. Dean, R.M., and Bishop, M.R. Graft-versus-host disease: emerging concepts in prevention and therapy. Curr Hematol Rep 2, 287, 2003.
16. Sakaguchi, Y., Sekiya, I., Yagishita, K., Ichinose, S., Shinomiya, K., and Muneta, T. Suspended cells from trabecular bone by collagenase digestion become virtually identical to mesenchymal stem cells obtained from marrow aspirates. Blood 104, 2728, 2004.
17. Jones, E.A., Kinsey, S.E., English, A., Jones, R.A., Straszynski, L., Meredith, D.M., Markham, A.F., Jack, A., Emery, P., and McGonagle, D. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 46, 3349, 2002.
18. Xu, W., Zhang, X., Qian, H., Zhu, W., Sun, X., Hu, J., Zhou, H., and Chen, Y. Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp Biol Med (Maywood) 229, 623, 2004.
19. Kornacker, M., Verneris, M.R., Kornacker, B., Scheffold, C., and Negrin, R.S. Survivin expression correlates with apoptosis resistance after lymphocyte activation and is found preferentially in memory T cells. Immunol Lett 76, 169, 2001.
20. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D., and Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315, 2006.
21. Horwitz, E.M., Le, B.K., Dominici, M., Mueller, I., Slaper-Cortenbach, I., Marini, F.C., Deans, R.J., Krause, D.S., and Keating, A. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7, 393, 2005.
22. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
23. DiGirolamo, C.M., Stokes, D., Colter, D., Phinney, D.G., Class, R., and Prockop, D.J. Propagation and senescence of human marrow stromal cells in culture: a simple colonyforming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 107, 275, 1999.
24. Galotto, M., Berisso, G., Delfino, L., Podesta, M., Ottaggio, L., Dallorso, S., Dufour, C., Ferrara, G.B., Abbondandolo, A., Dini, G., Bacigalupo, A., Cancedda, R., and Quarto, R. Stromal damage as consequence of high-dose chemo= radiotherapy in bone marrow transplant recipients. Exp Hematol 27, 1460, 1999.
25. Hacia, J.G., Lee, C.C., Jimenez, D.F., Karaman, M.W., Ho, V.V., Siegmund, K.D., and Tarantal, A.F. Age-related gene expression profiles of rhesus monkey bone marrow-derived mesenchymal stem cells. J Cell Biochem 103, 1198, 2008.
26. Zhang, H., Fazel, S., Tian, H., Mickle, D.A., Weisel, R.D., Fujii, T., and Li, R.K. Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapy. Am J Physiol Heart Circ Physiol 289, H2089, 2005.
27. Balana, B., Nicoletti, C., Zahanich, I., Graf, E.M., Christ, T., Boxberger, S., and Ravens, U. 5-Azacytidine induces changes in electrophysiological properties of human mesenchymal stem cells. Cell Res 16, 949, 2006.
28. Moscoso, I., Centeno, A., Lopez, E., Rodriguez-Barbosa, J.I., Santamarina, I., Filgueira, P., Sanchez, M.J., Dominguez-Perles, R., Penuelas-Rivas, G., and Domenech, N. Differentiation "in vitro" of primary and immortalized porcine mesenchymal stem cells into cardiomyocytes for cell transplantation. Transplant Proc 37, 481, 2005.
29. Toma, C., Pittenger, M.F., Cahill, K.S., Byrne, B.J., and Kessler, P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105, 93, 2002.
30. Beltrami, A.P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chimenti, S., Kasahara, H., Rota, M., Musso, E., Urbanek, K., Leri, A., Kajstura, J., Nadal-Ginard, B., and Anversa, P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114, 763, 2003.
31. Murry, C.E., Soonpaa, M.H., Reinecke, H., Nakajima, H., Nakajima, H.O., Rubart, M., Pasumarthi, K.B., Virag, J.I., Bartelmez, S.H., Poppa, V., Bradford, G., Dowell, J.D., Williams, D.A., and Field, L.J. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428, 664, 2004.
32. Rota, M., Kajstura, J., Hosoda, T., Bearzi, C., Vitale, S., Esposito, G., Iaffaldano, G., Padin-Iruegas, M.E., Gonzalez, A., Rizzi, R., Small, N., Muraski, J., Alvarez, R., Chen, X., Urbanek, K., Bolli, R., Houser, S.R., Leri, A., Sussman, M.A., and Anversa, P. Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci USA 104, 17783, 2007.
33. Aggarwal, S., and Pittenger, M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105, 1815, 2005.
34. Krampera, M., Cosmi, L., Angeli, R., Pasini, A., Liotta, F., Andreini, A., Santarlasci, V., Mazzinghi, B., Pizzolo, G., Vinante, F., Romagnani, P., Maggi, E., Romagnani, S., and Annunziato, F. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24, 386, 2006.
35. Zappia, E., Casazza, S., Pedemonte, E., Benvenuto, F., Bonanni, I., Gerdoni, E., Giunti, D., Ceravolo, A., Cazzanti, F., Frassoni, F., Mancardi, G., and Uccelli, A. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106, 1755, 2005.
36. Corcione, A., Benvenuto, F., Ferretti, E., Giunti, D., Cappiello, V., Cazzanti, F., Risso, M., Gualandi, F., Mancardi, G.L., Pistoia, V., and Uccelli, A. Human mesenchymal stem cells modulate B-cell functions. Blood 107, 367, 2006.
37. Spaggiari, G.M., Capobianco, A., Becchetti, S., Mingari, M.C., and Moretta, L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 107, 1484, 2006.